What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women?

Bedretdinova, Dina; Ambühl, David Philipp Josef; Omar, Muhammad Imran; Sakalis, Vasileios; Thiruchelvam, Nikesh; Schneider, Marc Philipp; Nambiar, Arjun; Bosch, Ruud (2020). What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women? (In Press). European urology focus Elsevier 10.1016/j.euf.2020.01.012

[img] Text
Am_What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women_270220.pdf
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

CONTEXT Nocturia is a prevalent symptom with varied aetiology and no consensus on treatment options. OBJECTIVE We systematically reviewed evidence comparing the benefits and harms of various treatment options for nocturia or nocturnal incontinence in women. EVIDENCE ACQUISITION Literature search was performed using Embase, Medline, and Cochrane databases (from 1 January 1946 to 26 September 2017), following the methods detailed in the Cochrane Handbook. The protocol was registered with PROSPERO. Certainty of evidence was assessed with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. EVIDENCE SYNTHESIS The literature search identified 3573 citations, of which 11 full-text articles were included. Three studies on desmopressin and four on antimuscarinics provided evidence of improving nocturia symptoms. Four studies on behavioural treatment provided limited evidence and controversial results. One study on oestrogen did not prove the benefit of any mode of administration, and one small study on functional magnetic stimulation provided some evidence of effectiveness in nocturia. One randomised controlled trial (RCT; 141 participants) reported a statistically significant difference between the desmopressin and placebo groups (desmopressin patients experienced 0.75 [95% confidence interval {CI} 0.47-1.03] nocturia episodes less than those experience by the placebo group; certainty of evidence = low). The only RCT on antimuscarinics in women with nocturia reported that oxybutynin reduced the number of nocturia episodes by 0.3 (95% CI -0.02 to 0.62) versus placebo. In one RCT comparing tolterodine with the combination of tolterodine with behavioural therapy, there was significant change from baseline nocturnal incontinence episodes in both groups. CONCLUSIONS There is some evidence that desmopressin and antimuscarinics are effective treatment options for nocturia; however, there is very limited evidence for other treatment options. The findings should be interpreted with caution as there were some methodological flaws in the included studies, particularly outcome heterogeneity. PATIENT SUMMARY This review identified several medical treatments for nocturia in women, such as desmopressin and antimuscarinics, which appear to improve the severity of the condition.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Ambühl, David Philipp Josef and Schneider, Marc Philipp

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2405-4569

Publisher:

Elsevier

Language:

English

Submitter:

Jeannine Wiemann

Date Deposited:

16 Mar 2020 13:35

Last Modified:

16 Mar 2020 13:35

Publisher DOI:

10.1016/j.euf.2020.01.012

PubMed ID:

32061540

Uncontrolled Keywords:

Antimuscarinics Desmopressin Nocturia Systematic review Treatment Women

BORIS DOI:

10.7892/boris.141109

URI:

https://boris.unibe.ch/id/eprint/141109

Actions (login required)

Edit item Edit item
Provide Feedback